New Society Committee appointments from ARI

Prof Geoff Richards and Dr Martin Stoddart from ARI have both been newly-appointed to important international society committees, in keeping with ARI’s aim to maintain and increase its academic standing world-wide.

14 February 2013

Geoff Richards discusses the future of publishing at a TERMIS plenary debate.

Prof Richards has been appointed as a member-at-large to the Tissue Engineering and Regenerative Medicine International Society—EU chapter (TERMIS-EU) Continental Council and has also been made the European representative of the world council for a three-year term. To accomplish its mission, TERMIS brings together the international community of persons engaged or interested in the field of tissue engineering and regenerative medicine and promotes education and research within the field of tissue engineering and regenerative medicine through regular meetings, publications and other forms of communication. The Society also serves as an international forum to promote the informed discussion of challenges and therapeutic benefits of the application of tissue engineering and regenerative medicine technologies. Richards wrote in his nomination that for TERMIS to succeed as a translational society it must not only encourage good researchers (as it already has), but must bring in world leaders of clinical expertise that also have clinical research expertise. TERMIS must aim to have clinical problem driven scientific innovation through focused R&D using the high level comprehensive knowledge base of the TERMIS members to solve current patient problems. This is how the AO Foundation succeeds through partnership in research and education through to patient care. Richards recently co-organized a Basic Science Focus Forum at the Orthopaedic Trauma Association (OTA) Annual conference in San Antonio, Texas in October 2012. He is also an Executive Committee member of the European ORS and a member of the World Orthopaedic Alliance (WOA). Richards and Prof Mauro Alini are also members of the organizing committee for WOA 1st World Congress (November 8–10) in Beijing 2013.

Dr Stoddart has been appointed for a three-year term as a member of the Basic Science Education Committee (BSEC) of the Orthopeadic Research Society (ORS). He is now the third member of AO Research Institute Davos who has recently served on a committee for the ORS. Alini was a member and chair of the Membership Committee and Richards was the ORS Program Committee topic chair for Infection. The vision of the ORS is to transform the future through unique global multidisciplinary collaborations, focusing on the increasingly complex challenges of orthopaedic patient treatment. Its mission is to advance the global orthopaedic research agenda through excellence in research, education, collaboration, communication and advocacy. The BSEC develops and promotes educational content and programs.

The ORS has 25 % of its membership from non-USA based scientists and now will partner with several scientific meetings outside of the USA to increase its International contribution. AO Research Institute Davos is proud that the eCM conference in June, a meeting which has been successfully running since 1999, will be co-branded with the ORS.

Since 2011, Dr Sibylle Grad has been a co-organizer of the ORS Spine Research Interest Group. The aims of the group are “to develop and strengthen collaborative research, identify underdeveloped areas and enlarge the spine research community.” The group discusses research priorities, team and resources, integration and clinical applications.

These appointments, and the eCM partnership with the ORS, continue to demonstrate AO Research Institute Davos’s international standing within the research community.

AO Research Institute Davos Members also have positions within Swiss societies.

Dr Daniel Arens has been appointed secretary in the managing board of SAVIR (Swiss Association of Veterinarians in Industry and Research) for the next two years. Prof Mauro Alini is the current President of The Swiss Bone and Mineral Society (two year term). Dr David Eglin is on the Executive Committee of the Swiss Society for Biomaterials (SSB). ​​​​​

Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.